Cite
Schreuder I, van der Sande MA, de Wit M, et al. Seroprevalence of HIV, hepatitis b, and hepatitis c among opioid drug users on methadone treatment in the netherlands. Harm Reduct J. 2010;7:25doi: 10.1186/1477-7517-7-25.
Schreuder, I., van der Sande, M. A., de Wit, M., Bongaerts, M., Boucher, C. A., Croes, E. A., & van Veen, M. G. (2010). Seroprevalence of HIV, hepatitis b, and hepatitis c among opioid drug users on methadone treatment in the netherlands. Harm reduction journal, 725. https://doi.org/10.1186/1477-7517-7-25
Schreuder, Imke, et al. "Seroprevalence of HIV, hepatitis b, and hepatitis c among opioid drug users on methadone treatment in the netherlands." Harm reduction journal vol. 7 (2010): 25. doi: https://doi.org/10.1186/1477-7517-7-25
Schreuder I, van der Sande MA, de Wit M, Bongaerts M, Boucher CA, Croes EA, van Veen MG. Seroprevalence of HIV, hepatitis b, and hepatitis c among opioid drug users on methadone treatment in the netherlands. Harm Reduct J. 2010 Oct 26;7:25. doi: 10.1186/1477-7517-7-25. PMID: 20977742; PMCID: PMC2988003.
Copy
Download .nbib